Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept - 04/05/19
Doi : 10.1016/j.jaci.2019.01.017
Carrie Brodmerkel, PhD a, ∗, Katherine Li, MS a, ∗, Sandra Garcet, PhD b, Karen Hayden, PhD a, Andrea Chiricozzi, PhD c, Inna Novitskaya, PhD b, Judilyn Fuentes-Duculan, MD b, Mayte Suarez-Farinas, PhD d, e, Kim Campbell, PhD a, James G. Krueger, MD, PhD b 
a Immunology Biomarkers, Janssen Research & Development, Spring House, Pa
b Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
c Institute of Dermatology, Catholic University - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
d Department of Population Health Science and Policy, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY
e Department of Genetics and Genomics Science, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY
| Janssen Research & Development, LLC, funded this study. |
|
| Disclosure of potential conflict of interest: C. Brodmerkel, K. Li, K. Hayden, and K. Campbell are employed by Janssen Research & Development, LLC, a wholly owned subsidiary of Johnson & Johnson (J&J) and own J&J stock/stock options. A. Chiricozzi has received personal fees as a consultant and/or speaker from AbbVie, Biogen, Janssen, LEO Pharma, Lilly, and Novartis. M. Suarez-Farinas has received research support (grants paid to institution) and/or personal fees from DBV, Genisphere, and Pfizer. J. G. Krueger has received research support (grants paid to institution) from AbbVie, Amgen, BMS, Boehringer, EMD Serono, Innovaderm, Kineta, LEO Pharma, Novan, Novartis, Paraxel, Pfizer, Regeneron, and Vitae and personal fees from AbbVie, Acros, Allergan, Aurigne, BiogenIdec, Boehringer, Escalier, Janssen, Lilly, Novartis, Pfizer, Roche, and Valeant. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2019
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 5
P. 1965-1969 - mai 2019 Retour au numéro
Article précédent
- ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity
- Lynn D. Condreay, Mathias N. Chiano, Li Li, Elizabeth Harris, Dana J. Fraser, Deborah A. Meyers, Eugene R. Bleecker, Courtney Crim, David Stempel, Steven W. Yancey, Soumitra Ghosh
- Selective IgA deficiency in humans is associated with reduced gut microbial diversity
- Silje Fjellgård Jørgensen, Kristian Holm, Magnhild Eide Macpherson, Christopher Storm-Larsen, Martin Kummen, Børre Fevang, Pål Aukrust, Johannes Roksund Hov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?